Practice Location

165 NATCHEZ TRACE AVE
BOWLING GREEN, KY 42103-7940

Phone: (270) 782-7800

What does DAVID RICHARDS research?

David B. Richards studies a wide range of medical conditions including ulcerative colitis, lung cancer, heart failure, psoriasis, and gum disease. He has researched innovative treatments such as guselkumab for ulcerative colitis, which helps reduce inflammation and improve tissue health. Additionally, he investigates how environmental factors like tree canopies can influence mortality rates, and he explores the potential of new medications and therapies that could enhance the quality of life for patients dealing with serious health issues. His studies also extend to the efficacy of mental health treatments, such as using a machine learning model to predict responses to therapy for depression.

Key findings

  • In patients treated with guselkumab for ulcerative colitis, there was a significant reduction in harmful proteins linked to inflammation, with positive tissue health improvements by week 12.
  • An increase of about 18% in tree cover in Swiss cities led to a 3.6% decrease in death rates from heart disease.
  • 89% of posterior teeth in patients with periodontitis survived for ten years after systematic periodontal treatment, with a survival rate of 95% for premolars.
  • In a study of 55 patients with advanced cholangiocarcinoma, 30% of those with specific FGFR2 gene changes experienced tumor reduction after treatment with tinengotinib.
  • After surgery for obstructive defecation syndrome, 82.5% of patients showed improvement in depressive symptoms and significant enhancements in bowel function.

Frequently asked questions

Does Dr. Richards study inflammatory bowel diseases?
Yes, he studies treatments for conditions like ulcerative colitis, focusing on how new therapies can reduce inflammation and improve tissue health.
What treatments has Dr. Richards researched for cancer?
He has researched tinengotinib for advanced cholangiocarcinoma, showing effectiveness in patients with specific genetic changes.
Is Dr. Richards's work relevant to mental health patients?
Yes, he investigates the effectiveness of treatment models like internet-delivered cognitive behavioral therapy for patients with depression.
How does Dr. Richards's research impact patients with periodontal disease?
His studies demonstrate that systematic periodontal treatment can significantly improve the long-term survival of teeth in patients with gum disease.
What is the significance of Dr. Richards's studies on tree canopies?
His research indicates that increased tree cover in urban areas is linked to lower mortality rates, particularly from heart disease, highlighting the importance of environmental health.

Publications in plain English

Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial.

2026

The lancet. Gastroenterology & hepatology

Javle M, Fountzilas C, Liao CY, Pelster M, Li D +15 more

Plain English
This study looked at a drug called tinengotinib for treating patients with advanced cholangiocarcinoma, which is a rare and aggressive liver cancer. Out of 55 patients who received the medication, the drug showed effectiveness primarily in those with specific FGFR2 gene changes; for example, 30% of patients who had previously resisted other FGFR-targeted treatments experienced a reduction in their tumors. This matters because it provides new treatment options for patients whose cancer has not responded to standard therapies, potentially improving their outcomes. Who this helps: Patients with advanced cholangiocarcinoma, particularly those with specific genetic changes.

PubMed

Ten-year survival of posterior teeth in patients with periodontitis following systematic periodontal treatment: A systematic review and meta-analysis using only open-access evidence and analytic tools.

2026

Journal of dentistry

Howe MS, Richards D

Plain English
This study looked at how long the back teeth (posterior teeth) of patients with gum disease (periodontitis) last after they receive treatment. It found that, on average, 89% of these teeth survived for ten years after treatment. Specifically, premolars had a survival rate of 95%, while molars had a lower survival rate of 85%. This is important because it shows that systematic periodontal treatment is effective in helping patients keep their back teeth for a long time. Who this helps: This benefits patients with gum disease and their dentists by providing evidence of treatment effectiveness.

PubMed

Response to "Skin as a sensor: Integrating biophysical wearables into dermatology".

2026

Journal of the American Academy of Dermatology

Ikoma A, Paller A, Richards D, Xu S

PubMed

WDR62 is required for proper proliferation and early differentiation of skeletal myoblasts.

2026

Communications biology

Ho UY, Shohayeb B, Kamei H, Morris MJ, Yeap YY +6 more

Plain English
This study looked at a protein called WDR62 and its importance in muscle cell development. Researchers found that mice without WDR62 had smaller muscles and showed signs of muscle cells maturing too quickly after injury—7 days post-injury, they had more immature muscle fibers than normal. This is significant because it highlights how WDR62 helps ensure proper muscle development by controlling when these muscle cells grow and mature. Who this helps: This helps patients recovering from muscle injuries and doctors aiming to improve healing processes.

PubMed

A new frontier: Translating IPC best practices for the carceral setting.

2026

American journal of infection control

Schultz A, Richards D, Zawitz C, Ciaccio M, Brown-Gomez E +3 more

PubMed

Tree canopy configuration and Swiss adult mortality at the municipal level: A nationwide ecological study.

2026

Environment international

Chi D, Manoli G, Yang J, Richards D, Hahs A +10 more

Plain English
This study looked at the impact of tree canopies in Swiss cities on adult death rates from natural causes, heart disease, and cancer. The researchers found that when tree cover increased by about 18%, there was a 3.6% decrease in heart disease deaths. Conversely, areas with more fragmented tree patches saw increases in death rates: 3.3% for natural causes and 4.9% for heart disease. Who this helps: This benefits city planners and public health officials aiming to improve community health through urban greening.

PubMed

Multiomic characterisation of the clinical efficacy of guselkumab induction therapy in ulcerative colitis.

2026

BMJ open gastroenterology

Hart A, Sridhar S, Venkat S, Lee T, Rusbuldt JJ +19 more

Plain English
This study looked at how well guselkumab, a medication that targets inflammation, works for patients with moderate to severe ulcerative colitis (UC). Out of 313 participants, those who received guselkumab showed a significant decrease in harmful inflammation markers in their blood by week 4 and continued improvement by week 12. The treatment seemed to promote healing in the gut tissue, which is crucial for improving patients' symptoms. Who this helps: This helps patients with ulcerative colitis looking for effective treatment options.

PubMed

Efficacy of subcutaneous sumatriptan in postcraniotomy pain and opioid consumption.

2025

Journal of neurosurgery

Woodward J, Kelly R, Herbst J, Patel A, Meza S +7 more

Plain English
This study looked at the use of sumatriptan, a drug typically used for migraines, to manage pain after brain surgery (craniotomy) and reduce the need for opioids. Researchers analyzed data from 300 patients, finding that those who received sumatriptan experienced significantly less pain at 12 hours (more than 30% reduction) and 24 hours after surgery, and they also consumed fewer opioids overall. This is important because it highlights a potential alternative to opioids that may minimize side effects and complications from traditional pain medications. Who this helps: Patients recovering from brain surgery.

PubMed

Load Management Among Professional Hockey Goalies: A Retrospective Cohort Study.

2025

Sports health

Ekhtiari S, Fahey C, Hache P, Hache R, Rubinger L +3 more

Plain English
This study looked at how the amount of games NHL goalies played during the regular season affected their performance in the playoffs. Researchers analyzed data from 51 goalies over six seasons and found that the regular season workload explained only 6.8% of their playoff performance, meaning there’s no solid evidence that limiting games in the regular season leads to better playoff results. This matters because it suggests that each goalie might need a personalized plan for their workload instead of following a uniform limit. Who this helps: This helps coaches and sports trainers develop better strategies for managing goalie workloads.

PubMed

Utility of Mechanistic Target of Rapamycin Inhibitors in Cardiac Sarcoidosis.

2025

Journal of cardiac failure

Richards D, Fujito H, Shanbhag A, Akhavan B, Frame E +6 more

Plain English
This study looked at four patients with active cardiac sarcoidosis who could not have higher doses of corticosteroids. After six months of treatment with a new type of medication called an mTOR inhibitor, two of the patients showed significant improvement, with their heart inflammation decreasing by more than 80%. This research is important because it explores alternative treatments for a serious condition, potentially reducing the complications linked to long-term steroid use. Who this helps: This helps patients with cardiac sarcoidosis who cannot tolerate corticosteroids.

PubMed

Sustainable solar energy deployment: a multi-criteria decision-making approach for site suitability and greenhouse gas emission reduction.

2025

Environmental science and pollution research international

Richards D, Yabar H, Mizunoya T, Koon Koon R, Tran GH +1 more

Plain English
This study looked at the best locations in Jamaica to set up large solar power plants to generate clean energy and reduce greenhouse gas emissions. Researchers identified 2,824 square kilometers of suitable land using different decision-making techniques, estimating that these sites could produce between 19.69 and 109.15 gigawatt-hours of electricity annually and cut carbon dioxide emissions by over 51,000 tons each year, saving about $3.28 million in costs. This is important because it helps Jamaica make better use of renewable energy and supports the country's environmental goals. Who this helps: This helps policymakers and energy investors in Jamaica.

PubMed

Implementing Internet-Delivered Cognitive Behavioral Therapy for Depression and Anxiety in Adults: Systematic Review.

2025

Journal of medical Internet research

Duffy D, Richards D, Hisler G, Timulak L

Plain English
This study looked at how to effectively use internet-delivered cognitive behavioral therapy (iCBT) for treating depression and anxiety in adults. The researchers analyzed 40 different studies and found that having guiding therapists can make iCBT more effective than doing it alone, and it works just as well as traditional face-to-face therapy. Understanding the factors that help or hinder the use of iCBT, such as staff management and legal regulations, is important for making it widely available. Who this helps: This benefits patients with depression and anxiety seeking convenient therapy options.

PubMed

Artificial Intelligence-Enabled Wearable Devices and Nocturnal Scratching in Mild Atopic Dermatitis.

2025

JAMA dermatology

Yang AF, Patel S, Chun KS, Richards D, Walter JR +4 more

Plain English
This study looked at how a special wearable device that uses artificial intelligence can help reduce nighttime scratching in adults with mild atopic dermatitis. The researchers found that when the device provided feedback to the users, the number of times they scratched during the night decreased by 28%, and the time spent scratching dropped by 50%. This is important because it offers a new, drug-free way to help people manage their skin condition and improve their sleep quality. Who this helps: This helps patients with mild atopic dermatitis who struggle with nighttime scratching.

PubMed

Real-world outcomes of generic elexacaftor/tezacaftor/ivacaftor (gETI) in South Africans (SA) with CF using standard versus clarithromycin-boosted gETI, modulator-sparing strategies to reduce cost.

2025

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Zampoli M, Verstraete J, Baird C, Biebuyck T, Calligaro G +8 more

Plain English
This study looked at how a less expensive version of a cystic fibrosis medication, called generic elexacaftor/tezacaftor/ivacaftor (gETI), worked for South African patients when boosted with another drug, clarithromycin, compared to standard doses. Over 18 months, the patients had significant improvements: their sweat chloride levels dropped by an average of 52.9 mmol/L, lung function (measured by FEV1 percentage) increased by about 15 points, and their body mass index (BMI) rose by 0.84. These findings are important because they demonstrate that a cost-effective treatment strategy can still provide high-quality care for cystic fibrosis patients in low-resource settings. Who this helps: This helps patients with cystic fibrosis and healthcare providers in resource-limited areas.

PubMed

Serum Collagen Biomarkers Are Reflective of Tissue Specific Fibroblasts Associated With Ulcerative Colitis Activity and Treatment Response to Ustekinumab.

2025

United European gastroenterology journal

Venkat S, Rusbuldt J, Richards D, Freeman T, Richmond C +5 more

Plain English
This study looked at specific proteins in the blood of patients with Ulcerative Colitis (UC) to see how they relate to certain types of cells in the intestines and the response to treatment with a drug called Ustekinumab. Researchers found that levels of certain collagen proteins in the blood, such as Pro-Collagen 22 and ELP-3, were closely linked to inflammation in the intestines and changes in patient condition, specifically in responders to treatment. This is important because it may help doctors identify patients who are likely to respond to treatment and guide new therapies for managing UC. Who this helps: This helps patients with Ulcerative Colitis and their healthcare providers.

PubMed

The Routine Collection of "Just-in-Case" Thyroid Aspirates for Molecular Testing at the Time of Initial Fine Needle Aspiration. Our Experience.

2025

Ultrasound quarterly

Dawkins A, Richards D, Sabujan A, Nair R

Plain English
This study looked at a method for collecting extra samples from thyroid nodules during initial biopsies to see if they might be cancerous. Out of 75 nodules tested, 60% of those considered at risk for cancer were actually found to be benign, which means using the extra samples helped avoid unnecessary follow-up procedures for many patients. This approach improved efficiency by reducing the need for repeat biopsies by 40% and is important because it reduces anxiety and inconvenience for patients. Who this helps: Patients with thyroid nodules facing potential surgery.

PubMed

Digital mental health treatment implementation playbook: successful practices from implementation experiences in American healthcare organizations.

2025

Frontiers in digital health

Mohr DC, Silverman AL, Youn SJ, Areán P, Bertagnolli A +29 more

Plain English
This study looked at how digital mental health treatments (tools that help with mental health via technology) are being implemented in American healthcare organizations. Researchers gathered insights from a group of healthcare systems and digital health companies to create a guide that outlines best practices for successfully applying these treatments. They found that having a clear playbook improves the process, making it easier for healthcare providers to integrate these tools effectively, which is important as mental health needs grow and technology evolves. Who this helps: This helps patients seeking mental health care and healthcare providers looking to improve treatment options.

PubMed

On Paper Diagnostics: A Brief History and Future Perspectives.

2025

Chimia

Khosla N, DeMello A, Richards D

Plain English
This research paper explores the history and future of paper-based medical tests, which have gained popularity due to their simplicity and ease of use. Researchers found that these tests can make complex diagnostic procedures accessible and practical for everyday use, bridging the gap between advanced laboratory technologies and patients who may not have access to specialized care. This is important because it can improve healthcare equity, especially in low and middle-income areas, where advanced diagnostics are often unavailable. Who this helps: Patients, particularly those in low and middle-income regions, will benefit from easier access to diagnostic testing.

PubMed

Residential tree canopy configuration and mortality in 6 million Swiss adults: a longitudinal study.

2025

The Lancet. Planetary health

Chi D, Manoli G, Lin B, Aerts R, Yang J +9 more

Plain English
This study looked at how the layout of tree canopies near people's homes in Switzerland affects their risk of dying from natural causes. The researchers analyzed data from over 6 million adults from 2010 to 2019 and found that more connected and less fragmented tree canopies significantly lowered mortality risk. Specifically, living in areas with better tree canopy configurations reduced death risk by 20% compared to those in fragmented areas. Who this helps: This benefits patients and communities by highlighting the importance of urban green spaces for health.

PubMed

What's with the Lump in the Throat? Globus, Dysphagia, and the Role of the Upper Esophageal Sphincter in Laryngopharyngeal Reflux Disease.

2025

Otolaryngologic clinics of North America

Koutroumpakis F, Richards D

Plain English
This study looked at two common throat issues: the feeling of a lump in the throat, known as globus, and the difficulty in swallowing (dysphagia), both of which can relate to stomach acid problems. Researchers found that patients with laryngopharyngeal reflux disease (LPR), a type of stomach reflux, have weaker defenses in their throat area that make it more likely for acid to come up and cause irritation. Improving the muscle barrier in the throat can help lessen the symptoms of LPR, which is important for better swallowing and comfort. Who this helps: This helps patients suffering from throat discomfort and difficulty swallowing caused by reflux disease.

PubMed

Digital health technology for Parkinson's disease with comprehensive monitoring and artificial intelligence-enabled haptic biofeedback for bulbar dysfunction.

2025

Journal of Parkinson's disease

Xu S, Kantarcigil C, Rangwala R, Nellis A, San Chun K +14 more

Plain English
Researchers developed a new digital health tool using sensors to help people with Parkinson's disease (PD) who have difficulty swallowing, known as dysphagia. In a study with 20 PD patients, this system increased their swallowing frequency by 45%, from 0.77 to 1.10 swallows per minute. This matters because it shows promise in improving the daily life of those suffering from swallowing issues in PD, which can significantly impact their health and wellbeing. Who this helps: This benefits patients with Parkinson's disease and their caregivers.

PubMed

Content validation and use of mothers on respect index to determine levels of respectful maternity care among women facing disadvantage, birthing in the Top End of the Northern Territory: a cross-sectional study.

2025

Frontiers in global women's health

Bowden ER, Toombs MR, Williams RL, Chang AB, Richards D +3 more

Plain English
This study looked at how respectful maternity care is experienced by First Nations, migrant, and refugee women in the Northern Territory of Australia. Researchers found that, overall, these women reported high levels of respectful care, with a median score of 78 out of 100. However, remote-living First Nations women scored lower at 63.5, indicating they may face more challenges. This is important because it highlights that some groups of women still experience less respect during maternity care, which can affect their health and willingness to seek help. Who this helps: This helps mothers, healthcare providers, and policymakers working to improve maternity care for disadvantaged groups.

PubMed

Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response.

2025

The Lancet. Microbe

Drennan PG, Provine NM, Harris SA, Otter A, Hollett K +22 more

Plain English
This study examined the effectiveness of the modified vaccinia Ankara (MVA-BN) vaccine in preventing mpox, especially when given at a lower dose. Researchers found that out of 30 participants who had not been previously vaccinated against smallpox, 47% developed antibodies by 28 days after the first shot, which increased to 89% after a second shot at 90 days. The findings highlight the importance of understanding how the immune system responds to the vaccine, which can help enhance vaccination strategies during mpox outbreaks. Who this helps: This benefits patients at risk for mpox, particularly in areas experiencing outbreaks.

PubMed

Editorial: The role of conversational AI in higher education.

2025

Frontiers in artificial intelligence

Otermans PCJ, Demetriadis S, Richards D

PubMed

Mechanisms of polysorbate 80 oxidation: Acetate and Fe(III) mediated near UV and visible light degradation enhanced by free fatty acids.

2025

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Wu Y, Richards D, Zhang Y, Zhang L, Dodd SW +1 more

Plain English
This study looked at how polysorbate 80 (PS80), an important ingredient in many medications, breaks down when exposed to light and certain chemical conditions. The researchers found that when PS80 is mixed with specific substances like acetate and iron (Fe(III)), it can degrade significantly—especially when small amounts of free fatty acids are present, which helps the degradation process. This is important because it shows that light exposure can compromise the effectiveness and stability of pharmaceutical products. Who this helps: This benefits patients and doctors by ensuring the medications remain effective and safe.

PubMed

REMOVED: Ivermectin and COVID-19.

2025

The Journal of infection

Butler CC, Hobbs FDR, Little P, Richards D, Saville BR +2 more

PubMed

Banbury Forum Consensus Statement on the Path Forward for Digital Mental Health Treatment.

2025

Focus (American Psychiatric Publishing)

Mohr DC, Azocar F, Bertagnolli A, Choudhury T, Chrisp P +11 more

Plain English
This study focused on improving access to mental health treatment in the U.S. by promoting digital mental health treatments (DMHTs), which are effective but underused. Experts concluded that all patients with common mental disorders should have access to guided DMHTs, and they recommended that insurance should cover these services to help integrate them into the healthcare system. This matters because making these treatments more accessible could reduce the burden of mental health issues on Americans. Who this helps: This helps patients struggling with mental health disorders who lack access to traditional therapy.

PubMed

Immune signaling mediates stromal changes to support epithelial reprogramming in celiac duodenum.

2025

Cell reports

Richards D, Sohn K, Basavarajappa SC, Horowitz D, Rusbuldt J +9 more

Plain English
This study examined how cells in the small intestine behave in people with celiac disease, a condition that affects about 0.5% to 1% of the population. Researchers analyzed over 203,000 individual cells and found that in these patients, there were more stem and secretory cells but fewer cells that absorb nutrients, indicating changes that can harm intestinal function. Understanding these cellular changes is important because it helps clarify how the immune system interacts with gut tissues when gluten is eaten, which could lead to better treatments for celiac disease. Who this helps: This helps patients with celiac disease and their doctors.

PubMed

Impact of COVID-19 on Patients with a Preferred Language Other than English in the Emergency Department.

2025

The western journal of emergency medicine

Thiessen M, Hopkins E, Whitfield J, Rodrigues K, Richards D +2 more

Plain English
This study looked at how the COVID-19 pandemic affected patients who prefer a language other than English when they visit the emergency room. Researchers found that while fewer patients visited the ER overall, the percentage of those speaking a different language increased from 16% to 19%, and this group represented 44% of all COVID-19 cases, even though they were only a small part of the total patients. They also found that this group was nearly three times more likely to test positive for COVID-19 than English speakers, highlighting the need for better language support and culturally appropriate care. Who this helps: This helps patients who speak languages other than English.

PubMed

Removal notice to "Ivermectin and COVID-19" Journal of Infection 91 (2025) 106530.

2025

The Journal of infection

Butler CC, Hobbs FDR, Little P, Richards D, Saville BR +2 more

PubMed

A Novel Approach to Differential Expression Analysis of Co-Occurrence Networks for Small-Sampled Microbiome Data.

2025

IEEE transactions on computational biology and bioinformatics

Gadhia N, Smyrnakis M, Liu PY, Blake D, Hay M +4 more

Plain English
This study explores a new method to analyze complex data from tiny samples of microbiomes, which are the tiny organisms living in animals' intestines. Researchers tested their approach on chickens affected by a specific disease, Eimeria tenella, and found that different types of bacteria and how they interact change as the disease progresses. Notably, they identified a stable group of bacteria that consistently appeared throughout the disease stages, which could help in developing targeted treatments. Who this helps: This helps doctors and researchers working on improving treatments for gut-related diseases in animals and potentially in humans.

PubMed

Improvement in functional and mental outcomes after resection rectopexy for obstructive defecation syndrome ODS.

2025

Scientific reports

Rudroff C, Madukkakuzhy J, Otten J, Schroer J, Richards D +2 more

Plain English
This study looked at how surgery for obstructive defecation syndrome (ODS), which makes bowel movements difficult and can cause mental distress, affects both bowel function and mental health. Out of 108 patients studied, 82.5% had some level of depression and 55.6% had anxiety before their surgery. After six months, patients showed marked improvements in bowel function and a decrease in depression symptoms, while only slight changes in anxiety were noted, indicating that fixing bowel issues can significantly boost mental well-being. Who this helps: Patients with obstructive defecation syndrome.

PubMed

Methods to Validate Digital Health Technologies for Dermatology.

2025

The Journal of investigative dermatology

Park JJ, Richards D, Tseng PH, Ebata T, Ikoma A +4 more

Plain English
This study looks at how digital health technologies, like wearable devices, are being used in dermatology to measure symptoms such as itching. It discusses different steps needed to make sure these devices are reliable and useful for patients, noting that issues like skin irritation can make it hard for people to wear them consistently. For instance, the study highlighted how sensors that track scratching in patients with atopic dermatitis are validated to ensure they provide accurate information. Who this helps: Patients with skin conditions and their doctors.

PubMed

Coronary Microvascular Dysfunction Related to Hydroxychloroquine-Induced Cardiomyopathy.

2025

JACC. Case reports

Richards D, Acharya D, Bannykh S, Thomson L, Kransdorf E +1 more

Plain English
This study examined a 69-year-old woman with rheumatoid arthritis who experienced worsening chest pain caused by hydroxychloroquine, a medication she was taking. The researchers found that her heart showed signs of damage, specifically a type of heart condition linked to the medication, which affected the small blood vessels in her heart. Recognizing this link helps improve how doctors diagnose and manage patients who may experience similar heart issues from this drug. Who this helps: This helps patients taking hydroxychloroquine and their doctors by highlighting potential heart risks.

PubMed

Harms of terminating NIH grants for kidney disease.

2025

Nature reviews. Nephrology

Roberts GV, Barber T, Jefferson NM, Turner-Gee Q, Richards D +4 more

Plain English
The study looked at the impact of stopping nearly 2,100 kidney disease research projects funded by the US National Institutes of Health (NIH) in early 2025. It highlighted that this decision could negatively affect patients and their communities who rely on advancements in kidney disease treatments. Over 32,000 people have supported a movement to keep the NIH focused on science instead of politics. Who this helps: This helps patients with kidney disease and their caregivers.

PubMed

Machine Learning Model for Response to Internet-Delivered CBT vs Antidepressant Medication.

2025

JAMA network open

Lee CT, Richards D, Heinzle J, Hanlon AK, Lynch K +6 more

Plain English
This study looked at how well a machine learning model could predict whether people with depression would respond to internet-delivered cognitive behavioral therapy (iCBT) or antidepressant medication. Out of nearly 2,700 people screened, 883 completed the study, and the model was able to predict iCBT responses with an accuracy of about 19.3%, compared to 10.8% for those on just antidepressants. This is important because it could help tailor treatments for depression based on individual characteristics, making care more effective. Who this helps: Patients suffering from depression who may benefit from personalized treatment options.

PubMed

Exon Utilization Improves Risk Stratification for Advanced Heart Failure in Titin Cardiomyopathy.

2025

medRxiv : the preprint server for health sciences

Deckerman P, Lee J, Binek A, Parker S, Luthringer DJ +10 more

Plain English
This study looked at how well a new way of measuring gene expression can help predict the risk of advanced heart failure in patients with a specific genetic condition called titin cardiomyopathy. Researchers tested heart tissue from 22 individuals and found that their new measure was better at indicating who would develop severe heart issues; specifically, 35% of patients had advanced heart failure. Using this new measurement could improve how doctors assess and manage patients at risk for worsening heart conditions. Who this helps: Patients with titin cardiomyopathy and their doctors.

PubMed

Peer-Delivered Hepatitis C Testing and Health Screening Provided in a Community Pharmacy Setting: Proof of Concept.

2025

Pharmacy (Basel, Switzerland)

Sankla N, Cottington R, Cowie C, Huggett P, Reid L +9 more

Plain English
This study looked at a new approach to hepatitis C testing by using trained peers in a community pharmacy to reach people who usually don’t get tested. Over two years, the program conducted 591 tests and found 24 people with an active infection. This matters because it shows that this method can effectively engage and support marginalized individuals in getting the healthcare they need. Who this helps: This benefits patients who might not seek traditional medical settings for testing and treatment.

PubMed

Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis.

2025

JCI insight

Strawn D, Krueger JG, Bissonnette R, Eyerich K, Ferris LK +29 more

Plain English
This research studied icotrokinra, a new oral treatment for moderate-to-severe psoriasis, which works by targeting the IL-23 receptor. The trial found that icotrokinra significantly lowered key markers of inflammation and psoriasis severity after 16 weeks, with the most effective dose being 100 mg taken twice daily. These results matter because they show that icotrokinra can effectively reduce disease symptoms and maintain improvement over time. Who this helps: Patients with moderate-to-severe psoriasis benefit from this treatment.

PubMed

Radiographic Analysis of Endplate Coverage of a 3-Dimensional-Expandable Transforaminal Lumbar Interbody Fusion (TLIF) Implant Compared to Static TLIF and Anterior Lumbar Interbody Fusion Implants.

2025

Neurospine

Mazza J, Siddiqi M, Kolcun JPG, Richards D, Fessler RG

Plain English
This study looked at how well different types of spinal implants cover the bone surfaces at the ends of vertebrae during surgery. Researchers found that the 3D-expandable implants cover more area than static implants, with an average coverage ratio of 0.35, compared to 0.19 for static implants and 0.46 for anterior implants; both the static and 3D-expandable implants showed similar coverage in certain areas. This matters because better coverage can lead to more stable spinal fusions and improved patient outcomes. Who this helps: Patients undergoing spinal fusion surgery.

PubMed

Presentation of the first international research network to foster high-quality clinical trials testing non-pharmacological interventions (TRACTION network).

2024

BMJ open

Ferreira RJO, Henriques A, Moe RH, Matos C, Tveter AT +6 more

Plain English
The TRACTION network is a new international group aimed at improving clinical trials for non-drug treatments, which are often more complex and face unique challenges. It plans to help researchers with various aspects of conducting these trials, such as recruiting participants and managing data, ensuring they are high-quality and effective. This is important because better trials can lead to improved care and outcomes for patients. Who this helps: Patients and healthcare providers.

PubMed

Diagnostic and prognostic value of the left atrial myopathy evaluation in cardiac amyloidosis using echocardiography.

2024

ESC heart failure

Ferkh A, Geenty P, Stefani L, Emerson P, Pham J +7 more

Plain English
This study looked at how well doctors can identify and predict the outcomes of patients with cardiac amyloidosis, a type of heart failure, by examining the left atrium of the heart using echocardiography. They found that patients with one type of amyloidosis (ATTR) had significantly worse heart function and more issues with how their heart chambers work together compared to those with another form (AL) and compared to patients with high blood pressure. Specifically, a marker called left atrial mechanical dispersion was found to be higher in ATTR patients, indicating a poorer prognosis, and a minimum left atrial volume predicted higher mortality in the AL group. Who this helps: This research benefits patients with cardiac amyloidosis and their doctors by improving diagnosis and treatment planning.

PubMed

Decision Aid-Led Tapering of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Qualitative Study.

2024

The Journal of rheumatology

Lee J, Barber CEH, Jung M, Kaminska E, Bansback N +4 more

Plain English
This study looked at how patients with rheumatoid arthritis (RA) and their doctors felt about using a tool to help decide whether to reduce their medication. Ten patients who had been stable on their treatment felt confident using this tool, while 12 rheumatologists had mixed feelings, with some fully supporting it and others worried about potential risks. Overall, the tool made it easier for patients to discuss lowering their medication during doctor visits, showing it can be a helpful way to manage treatment in stable patients. Who this helps: This benefits patients with rheumatoid arthritis and their doctors.

PubMed

Hydroquinone impairs trophoblast migration and invasion via AHR-twist-IFITM1 axis.

2024

Placenta

Maxwell A, Swanson G, Thy Nguyen A, Hu A, Richards D +6 more

Plain English
This study looked at how a chemical called hydroquinone, found in benzene, affects the migration and invasion of trophoblast cells, which are essential for early pregnancy. The researchers found that hydroquinone made it harder for these cells to move and invade, specifically noting that it activated a pathway (called the AhR pathway) which decreased the levels of important proteins (Twist1 and IFITM1) that help with these processes. This matters because understanding how air pollution can lead to pregnancy problems like miscarriages could help develop preventive measures. Who this helps: This helps patients who are pregnant or trying to conceive, as well as healthcare providers.

PubMed

Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.

2024

The Journal of infection

Hobbs FR, Gbinigie-Thompson OA, Shanyinde M, Yu LM, Harris V +22 more

Plain English
This study looked at whether favipiravir, a medication, helps people in the community recover faster from COVID-19 compared to usual treatments. It involved 8,811 adults, with those taking favipiravir recovering about 3 days sooner than those receiving usual care (13 days vs. 16 days). While favipiravir did not lower hospital admissions or deaths, it did help more people feel fully recovered by six months (74.9% vs. 71.3%). Who this helps: This helps patients with mild to moderate COVID-19 symptoms.

PubMed

Autochthonous Human Babesia divergens Infection, England.

2024

Emerging infectious diseases

Zabala GA, Lever R, Chan XH, Bristowe H, Kilbride E +8 more

Plain English
This research paper reports on a woman in England who became infected with a parasite called Babesia divergens, leading to severe symptoms like fever, organ failure, and a significant level of the parasite in her blood (18% parasitemia). The infection was confirmed through genetic testing. This finding is important because it highlights the need for doctors to consider this rare disease when patients present with unexplained blood issues. Who this helps: This helps doctors making diagnoses for patients with similar symptoms.

PubMed

Advances in laryngopharyngeal reflux: Etiology, diagnosis, and management.

2024

Annals of the New York Academy of Sciences

Samuels TL, Aoun J, Husain I, Figueredo E, Richards D +1 more

Plain English
This study looked at laryngopharyngeal reflux (LPR), a condition that causes various throat and digestive symptoms due to stomach acids coming back up. Researchers found that LPR is not just one problem but a range of conditions that affect people differently. They noted that certain tests and treatments, like specific monitoring methods and medications, can help tailor care to individual needs, although some of these options are not widely available or can be costly. Who this helps: This helps patients suffering from LPR and healthcare providers looking for effective treatments.

PubMed

Realist assessment of fidelity during the implementation of the PARTNERS collaborative care intervention for people with diagnoses of severe mental illness within a cluster randomised controlled trial.

2024

PLOS mental health

Hobson-Merrett C, Frost J, Gwernan-Jones R, Pinfold V, Clark M +9 more

Plain English
This study looked at how well a collaborative care program called PARTNERS was implemented for people with severe mental illnesses. Researchers interviewed 39 participants, reviewed session recordings, and examined various logs to see how closely the actual delivery matched the intended model. They found that while the program was generally delivered well, there were variations based on the practitioner's experience and other factors, highlighting that improvements over time were linked to better understanding, but systemic issues in supervision may have hindered consistent application. Who this helps: This helps patients with severe mental illnesses by improving the care they receive from mental health practitioners.

PubMed

Management of pain and sedation in the intensive care unit.

2024

BMJ (Clinical research ed.)

Boncyk C, Rolfsen ML, Richards D, Stollings JL, Mart MF +2 more

Plain English
Researchers studied how pain and sedation are managed in intensive care units (ICUs) and found that using pain relief first, lighter sedation, and avoiding certain medications like benzodiazepines can help patients be more alert and involved during recovery. The study noted that since the COVID-19 pandemic, adherence to these best practices has declined, which can negatively impact patient outcomes. Improving pain and sedation management is crucial for better patient recovery after critical illnesses. Who this helps: Patients in intensive care units and their families.

PubMed

Frequent Co-Authors

Darren Ruane Shuai Xu Akihiko Ikoma Amy S Paller Christopher C Butler Paul Little Benjamin R Saville Ly-Mee Yu Swati Venkat

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.